PCK 3.57% 2.7¢ painchek ltd

CEO Philip Daffas believes approval is not the main challenge,...

  1. 3,540 Posts.
    lightbulb Created with Sketch. 223
    CEO Philip Daffas believes approval is not the main challenge, it will be channel marketing the product to different groups. The first is of course aged care facilities, and these groups like to see implementation studies which take time, so no contracts next few months. Hopefully the first implementation study works well and this will be used to apply for CE Mark (Europe) and TGA (Australia). Build credibility in a select group of clients first and then expand.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $44.16M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $55.36K 1.977M

Buyers (Bids)

No. Vol. Price($)
3 219510 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 91030 1
View Market Depth
Last trade - 15.56pm 28/06/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.